Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - GROSS PROFIT
Gross Profit HALO - Halozyme Therapeutics, Inc.
856 M
LAST VALUE
28.20%
2 YEAR CAGR
41.58%
5 YEAR CAGR
32.17%
10 YEAR CAGR